{"gene":"NKX2-2","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":1999,"finding":"Nkx2.2 is required for interpreting graded Sonic hedgehog signals and specifying ventral interneuron identity in the neural tube; in Nkx2.2 mutants, progenitor cells undergo a ventral-to-dorsal fate transformation and generate motor neurons rather than V3 interneurons, demonstrating Nkx2.2 has a primary role in neuronal patterning downstream of Shh.","method":"Genetic loss-of-function (Nkx2.2 null mouse), immunohistochemistry, in situ hybridization for cell-type markers","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, replicated across multiple labs","pmids":["10217145"],"is_preprint":false},{"year":1998,"finding":"Nkx2.2 is required for the final differentiation of pancreatic beta cells; in its absence, beta-cell precursors expressing IAPP and Pdx1 fail to complete differentiation and lack Glut2 and Nkx6.1, resulting in severe neonatal hyperglycemia and death.","method":"Genetic loss-of-function (Nkx2.2 null mouse), immunohistochemistry, in situ hybridization","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, foundational paper with >500 citations","pmids":["9584121"],"is_preprint":false},{"year":2001,"finding":"Coexpression of Olig2 with Nkx2.2 in the spinal cord promotes ectopic and precocious oligodendrocyte differentiation; both proteins function as transcriptional repressors in this context, and the effect is blocked by Neurogenin1.","method":"In vivo misexpression/overexpression in chick spinal cord, reporter assays, loss-of-function analysis","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — in vivo gain-of-function plus epistasis with Neurogenin1, >400 citations","pmids":["11567617"],"is_preprint":false},{"year":2001,"finding":"Nkx2.2 controls the differentiation and maturation of oligodendrocyte progenitors; loss of Nkx2.2 dramatically retards MBP+ and PLP-DM20+ oligodendrocyte differentiation, and overproduction of Nkx2.2 in fibroblasts can induce PLP promoter expression, demonstrating direct regulation of oligodendrocyte differentiation.","method":"Nkx2.2 null mouse loss-of-function, in vitro overexpression/reporter assay, immunohistochemistry","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — clean KO plus gain-of-function with defined phenotypic readout, >300 citations","pmids":["11526078"],"is_preprint":false},{"year":2000,"finding":"Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation; Nkx6.1/Nkx2.2 double mutant islet development is identical to Nkx2.2 single mutant, placing Nkx6.1 downstream of Nkx2.2 via genetic epistasis.","method":"Genetic epistasis — Nkx6.1/Nkx2.2 double-mutant mouse analysis, immunohistochemistry","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — double-mutant epistasis experiment, >400 citations","pmids":["11076772"],"is_preprint":false},{"year":2006,"finding":"NKX2.2 is a critical target gene of EWS/FLI in Ewing's sarcoma; ongoing EWS/FLI expression induces NKX2.2, and NKX2.2 is necessary for the tumorigenic/oncogenic transformation phenotype of Ewing's sarcoma cells.","method":"Retroviral-mediated RNA interference knockdown, reexpression studies, gene expression profiling","journal":"Cancer Cell","confidence":"High","confidence_rationale":"Tier 2 — RNAi knockdown plus reexpression rescue with functional oncogenic phenotype readout, >290 citations","pmids":["16697960"],"is_preprint":false},{"year":2008,"finding":"NKX2.2 mediates transcriptional repression downstream of EWS/FLI in Ewing's sarcoma; the DNA-binding and repressor domains are required for oncogenesis while the activation domain is dispensable; NKX2.2 recruits TLE (Groucho) and HDAC co-repressors; ChIP-chip confirmed direct binding of NKX2.2 to repressed target gene loci.","method":"Structure-function mutagenesis, microarray, ChIP-chip, pharmacological blockade of TLE/HDAC, reporter assays","journal":"PLoS ONE","confidence":"High","confidence_rationale":"Tier 1–2 — structure-function mutagenesis plus ChIP-chip and pharmacological epistasis, multiple orthogonal methods","pmids":["18414662"],"is_preprint":false},{"year":2011,"finding":"Nkx2.2 forms a large repression complex in pancreatic beta cells that includes DNMT3a, Grg3, and HDAC1; the Tinman (TN) domain of Nkx2.2 mediates interaction with Grg3; Nkx2.2 preferentially recruits Grg3 and HDAC1 to the methylated Arx promoter in beta cells to repress Arx and prevent beta-to-alpha cell transdifferentiation.","method":"Co-immunoprecipitation, endogenous TN-domain knock-in mutation in mice, beta-cell-specific DNMT3a deletion, Arx removal rescue experiment, ChIP","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including Co-IP, in vivo knock-in mutagenesis, conditional KO rescue","pmids":["22056672"],"is_preprint":false},{"year":2003,"finding":"Olig2 forms a physical protein complex with Nkx2.2 in mammalian cells and yeast two-hybrid assays; this interaction is specific (Olig2 does not bind Nkx6.1; Nkx2.2 does not bind NeuroD); physical complex formation underlies the cross-repressive interaction that establishes the pMN-p3 boundary in the developing spinal cord.","method":"Co-immunoprecipitation, yeast two-hybrid, deletion mapping","journal":"Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus yeast two-hybrid with specificity controls","pmids":["14573534"],"is_preprint":false},{"year":2014,"finding":"Nkx2.2 is a key regulator of the timing of oligodendrocyte differentiation; induced Nkx2.2 expression causes precocious OPC differentiation while conditional ablation delays maturation; Nkx2.2 directly binds the Pdgfra promoter and represses its expression; genetic ablation of Pdgfra mimics Nkx2.2 overexpression in accelerating OPC differentiation.","method":"Conditional knockout, overexpression, ChIP (Nkx2.2 binding to Pdgfra promoter), genetic epistasis (Pdgfra ablation)","journal":"Development","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo conditional KO plus ChIP plus genetic epistasis, multiple orthogonal methods","pmids":["24449836"],"is_preprint":false},{"year":2003,"finding":"Lmx1b and Pet-1 act downstream of Nkx2.2 to specify the serotonergic neurotransmitter phenotype; ectopic expression of all three (Lmx1b + Pet-1 + Nkx2.2) drives 5-HT differentiation in dorsal spinal cord, defining a molecular pathway necessary and sufficient for serotonergic fate.","method":"Genetic loss-of-function (Lmx1b null mice), ectopic gain-of-function in chick spinal cord, epistasis analysis","journal":"Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — epistasis defined by KO and ectopic expression reconstitution in vivo","pmids":["14602809"],"is_preprint":false},{"year":2005,"finding":"Nkx2.2 represses myelin basic protein (MBP) gene expression in oligodendrocyte progenitors by binding two regulatory elements in the MBP promoter, recruiting an HDAC1-mSin3A co-repressor complex, and blocking binding of the activator Puralpha; Sp1 can compete off Nkx2.2 binding and reverse repression, thereby allowing MBP expression in mature oligodendrocytes.","method":"In vitro DNA binding assays, promoter reporter assays, co-immunoprecipitation (HDAC1-mSin3A complex), competition assays","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro binding plus Co-IP of co-repressor complex plus in vivo reporter assays","pmids":["15695521"],"is_preprint":false},{"year":2007,"finding":"Nkx2.2 repressor activity (via Engrailed-repressor fusion) is sufficient to fully rescue glucagon-producing alpha-cells and partially rescue beta-cells in Nkx2.2 null mice; Grg3 physically interacts with Nkx2.2 through its TN domain in the embryonic pancreas, mediating co-repressor function.","method":"Transgenic dominant-derivative rescue in Nkx2.2 null mice, co-immunoprecipitation (Nkx2.2-Grg3 interaction via TN domain), immunohistochemistry","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — in vivo rescue plus Co-IP with domain mapping","pmids":["17202186"],"is_preprint":false},{"year":2009,"finding":"Nkx2.2 cooperatively activates NeuroD1 transcription with Ngn3; Nkx2.2 directly binds one NeuroD1 promoter element and indirectly regulates another; Nkx2.2 is necessary to maintain high NeuroD1 expression in developing islets and mature beta cells, placing Nkx2.2 upstream of NeuroD1.","method":"Genetic loss-of-function (Nkx2.2 null mouse and zebrafish morpholino), ChIP, reporter assays, promoter mutagenesis","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo KO plus ChIP plus promoter mutagenesis in two species","pmids":["19759004"],"is_preprint":false},{"year":2002,"finding":"Nkx2.2 directly occupies insulin gene control region sequences in intact beta cells in vivo; Nkx2.2 also binds to regulatory regions of islet amyloid polypeptide, Pax4, and glucokinase genes in vivo, demonstrating direct transcriptional regulation of multiple islet beta-cell genes.","method":"Chromatin immunoprecipitation (ChIP) from intact beta cells, in vitro DNA binding (EMSA), transient transfection reporter assays","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vivo ChIP plus in vitro binding confirmation, multiple target genes","pmids":["12426319"],"is_preprint":false},{"year":2007,"finding":"Nkx2.2 is required in the mature beta cell for maintenance of MafA and Glut2 expression, insulin gene expression, pancreatic insulin content, and glucose-stimulated insulin secretion; a dominant repressor derivative of Nkx2.2 disrupts endogenous Nkx2.2 function in adult beta cells, causing glucose intolerance and diabetes.","method":"Transgenic mouse overexpression of Nkx2.2 repressor derivative in adult beta cells, metabolic phenotyping, gene expression analysis","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — transgenic dominant-negative approach with defined molecular and metabolic phenotypes","pmids":["17456846"],"is_preprint":false},{"year":2006,"finding":"FoxA2, Nkx2.2, and PDX-1 directly bind a conserved beta-cell-specific region (region 3, bp -8118 to -7750) of the mafA promoter in vivo and cooperatively activate mafA transcription; Nkx2.2 binding at bp -7771 to -7746 mediates region 3 activation.","method":"ChIP, reporter assays, promoter mutagenesis, siRNA knockdown of PDX-1","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo ChIP plus mutagenesis plus functional reporter assays","pmids":["16847327"],"is_preprint":false},{"year":2011,"finding":"Nkx2.2 directly binds the Sirt2 promoter via HDAC1 in oligodendroglial precursor (CG4) cells, negatively regulating Sirt2 expression; HDAC1 knockdown attenuates Nkx2.2 binding and releases Sirt2 repression; Nkx2.2 overexpression down-regulates Sirt2 and delays CG4 cell differentiation.","method":"ChIP (Nkx2.2 and HDAC1 binding to Sirt2 promoter), siRNA knockdown of HDAC1, overexpression of Nkx2.2 and Sirt2 in CG4 cells, reporter assays","journal":"Journal of Molecular Cell Biology","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP plus HDAC1 knockdown epistasis plus overexpression phenotype","pmids":["21669943"],"is_preprint":false},{"year":2010,"finding":"Nkx2.2 and Nkx2.9 are required together to establish V3 interneuron fate by repressing the motor neuron lineage program (including Olig2) in the p3 domain; double mutant mice lack V3 interneurons and show conversion to motor neuron fate; additionally, both factors are required for floor plate development and commissural axon guidance.","method":"Nkx2.2/Nkx2.9 double-mutant mouse, cell fate analysis, axon tracing, locomotor activity assays","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — double-mutant genetic epistasis with multiple cellular phenotypic readouts","pmids":["21068056"],"is_preprint":false},{"year":2000,"finding":"The homeodomain of Nkx2.2 contains two cooperatively acting nuclear localization signals (NLS): a proximal NLS (KKRKRR) at the N-terminus of the homeodomain and a distal NLS (RYKMKRAR) at its C-terminus; each NLS is individually sufficient but inefficient for nuclear transport, and both act cooperatively for complete nuclear import.","method":"Deletion mutagenesis, nuclear localization assays in transfected cells","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with localization readout, single lab","pmids":["10772886"],"is_preprint":false},{"year":2004,"finding":"Pax4 and Nkx2.2 genetically interact to initiate pancreatic beta-cell differentiation; loss of Pax4 prevents expression of Pdx1, HB9, and insulin in beta-cell precursors, and this role is accomplished via genetic interaction with Nkx2.2.","method":"Pax4 knockout mouse, immunohistochemistry, genetic interaction analysis","journal":"Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined phenotype, genetic interaction inferred but not fully epistatic double mutant","pmids":["14729487"],"is_preprint":false},{"year":2007,"finding":"Nkx2.2 regulates cell fate choices in intestinal enteroendocrine cell lineages; in Nkx2.2 null mice, several hormone-producing enteroendocrine populations are absent/reduced and ghrelin-producing cells expand; Nkx2.2 functions upstream of Pax6 in intestinal enteroendocrine cell fate.","method":"Nkx2.2 null mouse, immunohistochemistry, RT-PCR, Pax6 expression analysis as downstream marker","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cell fate phenotype and epistasis placement upstream of Pax6","pmids":["18022152"],"is_preprint":false},{"year":2017,"finding":"Nkx2.2 acts primarily downstream of Neurog3 (endocrine progenitor cells) and functions as an integral component of a modular regulatory program to specify pancreatic islet cell fates; Neurog3-Cre-specific deletion of Nkx2.2 recapitulates the full Nkx2.2 null pancreatic phenotype, demonstrating essential activity in the endocrine progenitor population.","method":"Neurog3-Cre conditional knockout of Nkx2.2, immunohistochemistry, gene expression analysis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific conditional KO with defined phenotypic and molecular readouts","pmids":["28071588"],"is_preprint":false},{"year":2009,"finding":"Nkx2.2 directly binds to and activates the ghrelin promoter in multiple cell lines; the promoter region between -619 and -488 bp upstream of the translational start site is necessary for repression of ghrelin in alpha and beta cell lines; upregulation of ghrelin in Nkx2.2 null mice is not due to loss of promoter repression but suggests Nkx2.2 contributes to ghrelin activation in epsilon cells.","method":"Promoter reporter assays, ChIP, Nkx2.2 null mouse analysis, luciferase deletion constructs","journal":"Molecular Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus reporter assays, single lab","pmids":["19965928"],"is_preprint":false},{"year":2020,"finding":"NKX2-2 regulates oligodendrocyte differentiation through domain-specific co-repressor interactions: the N-terminal Tinman (TN) domain recruits GRG3, while the C-terminal domain recruits HDAC1 and DNMT3A; these domains synergistically promote oligodendrocyte differentiation; the NK2-specific domain suppresses the C-terminal domain function in oligodendrocyte differentiation.","method":"Co-immunoprecipitation, in ovo electroporation in chick spinal cord, domain deletion mutagenesis, immunofluorescence, in situ hybridization","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — Co-IP with domain mutagenesis plus in vivo functional assay","pmids":["31932307"],"is_preprint":false},{"year":2015,"finding":"NKX2.2 mediates EWS/FLI-controlled repression of mesenchymal features in Ewing sarcoma; NKX2.2 represses cell adhesion and extracellular matrix genes including zyxin; NKX2.2-depleted cells display increased focal adhesions, actin stress fibers, cell spreading, migration, and substrate adhesion.","method":"RNA sequencing, NKX2.2 knockdown, immunofluorescence of focal adhesion markers, migration assays","journal":"Genes & Cancer","confidence":"Medium","confidence_rationale":"Tier 2 — RNA-seq plus KD with defined cellular phenotype, single lab","pmids":["26000096"],"is_preprint":false},{"year":2016,"finding":"In the intestine, Nkx2.2 regulates enteroendocrine cell specification in a stage-dependent manner; serotonin-producing enterochromaffin cells are most severely reduced in all Nkx2.2 mutant conditions; Lmx1a is expressed in enterochromaffin cells and functions downstream of Nkx2.2; Lmx1a deficiency reduces Tph1 expression.","method":"Stage- and cell-type-specific conditional Nkx2.2 deletion, Lmx1a knockout mouse, immunohistochemistry, RT-PCR","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — multiple conditional KOs with epistasis showing Lmx1a downstream of Nkx2.2","pmids":["27287799"],"is_preprint":false},{"year":2023,"finding":"The NK2-specific domain (SD) of NKX2.2 is required for beta-cell-specific functions: SD mutation prevents developmental progression of beta-cell precursors into mature insulin-expressing beta cells and impairs adult beta-cell function; SD-dependent effects may be mediated via interactions with chromatin remodelers and nuclear pore complex components; the SD is dispensable for NKX2.2-dependent CNS cell type development.","method":"Endogenous SD knock-in mutation in mice, beta-cell phenotyping, gene expression analysis, proteomics/interaction studies","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1–2 — endogenous domain knock-in mutation with parallel tissue comparison, multiple phenotypic and molecular readouts","pmids":["37364986"],"is_preprint":false},{"year":2016,"finding":"Nuclear import of Nkx2-2 is mediated by multiple pathways: importin alpha1/beta1 (classical pathway), direct importin beta1 binding, and direct importin 13 binding; mutation of NLS1 or NLS2 reduces binding to importin beta1 but not to importin alpha1 or importin 13.","method":"Co-immunoprecipitation, GST pull-down, in vitro nuclear import assays, siRNA knockdown of importins, NLS mutagenesis","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro import assays plus pull-down plus mutagenesis, single lab","pmids":["27956177"],"is_preprint":false},{"year":2024,"finding":"NKX2-2 represses the proneural gene NEUROG2 by two distinct mechanisms in rodent versus human spinal progenitors: in rodents, NKX2-2 represses Olig2 via the Tinman domain leading to loss of Neurog2; in human vpMN progenitors, NKX2-2 represses NEUROG2 but not OLIG2 via a Notch- and Tinman-independent mechanism, allowing protracted motor neurogenesis; ectopic tinman-mutant Nkx2-2 in mouse pMNs phenocopies human vpMNs.","method":"In vivo mouse pMN ectopic expression of tinman-mutant Nkx2-2, human and rodent spinal organoid/progenitor analysis, gene expression studies","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — domain mutagenesis with in vivo functional readout in two species, single preprint","pmids":["39415990"],"is_preprint":true},{"year":2025,"finding":"CHD4 (chromodomain helicase DNA-binding protein 4) is an NKX2.2 interacting partner identified by unbiased proteomics; CHD4 and NKX2.2 cooperatively bind and repress non-beta-cell genes in beta cells, including Kcnj5 (GIRK4); aberrant GIRK4 upregulation upon Chd4 deletion impairs glucose-stimulated insulin secretion.","method":"Unbiased proteomics screen, co-immunoprecipitation, conditional Chd4 beta-cell KO mouse, gene expression analysis, calcium signaling assays","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — proteomics-identified interaction confirmed by Co-IP plus conditional KO with defined molecular phenotype, preprint","pmids":["40667117"],"is_preprint":true},{"year":2025,"finding":"KLF4 is expressed preferentially in pancreatic alpha cells, co-occupies NKX2.2-bound alpha-cell promoters, is necessary for NKX2.2 promoter occupancy in alpha cells, and coregulates NKX2.2 alpha-cell transcriptional targets; KLF4 overexpression in beta cells manipulates chromatin accessibility and increases NKX2.2 binding at alpha-cell-specific promoters.","method":"ChIP-seq (NKX2.2 and KLF4 co-occupancy), conditional/cell-type-specific KO, Klf4 overexpression in beta cells, chromatin accessibility (ATAC-seq)","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP-seq co-occupancy plus conditional KO plus gain-of-function with chromatin readout","pmids":["39797760"],"is_preprint":false},{"year":2014,"finding":"NKX2-2 mutations cause permanent neonatal diabetes in humans, confirming the conserved role of NKX2-2 in human beta-cell development analogous to its role in mice.","method":"Homozygosity analysis and Sanger sequencing in consanguineous neonatal diabetes patients; phenotypic comparison to mouse KO","journal":"Cell Metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — human genetics with phenotypic correspondence to mouse KO; functional mechanism inferred by analogy","pmids":["24411943"],"is_preprint":false},{"year":2014,"finding":"Mammalian Nkx2.2+ perineurial glia are essential for motor nerve development and Schwann cell differentiation; in mice lacking Nkx2.2, motor nerve development is impaired, demonstrating a role for Nkx2.2+ CNS-derived cells in peripheral nervous system formation.","method":"Nkx2.2:EGFP transgenic reporter, Nkx2.2 null mouse loss-of-function, immunolabeling, RNA expression analysis","journal":"Developmental Dynamics","confidence":"Medium","confidence_rationale":"Tier 2 — KO with defined cellular phenotype in perineurial glia, single lab","pmids":["24979729"],"is_preprint":false},{"year":2011,"finding":"Nkx2.2 and Arx genetically interact to regulate pancreatic endocrine cell specification; in Nkx2.2 null background, Arx is necessary for ghrelin mRNA upregulation in epsilon cells but not for ghrelin cell expansion; in absence of Arx, Nkx2.2 becomes essential for repression of somatostatin gene expression.","method":"Nkx2.2/Arx compound conditional knockout in pancreatic progenitors, immunohistochemistry, RT-PCR","journal":"Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 — double-mutant genetic analysis with defined hormone expression phenotypes","pmids":["21856296"],"is_preprint":false},{"year":2022,"finding":"Gata2, Nkx2-2, and Skor2 form a transcription factor network regulating development of midbrain GABAergic REM-sleep regulatory neurons; Gata2 is required for Nkx2-2 expression, and both Gata2 and Nkx2-2 are required for Skor2 expression in GABAergic precursors, placing Nkx2-2 downstream of Gata2 and upstream of Skor2.","method":"Gata2 and Nkx2-2 conditional knockout mice, immunohistochemistry, REM sleep activity assays, axon projection analysis","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis in multiple KO backgrounds with neuronal phenotype and functional readout","pmids":["35815619"],"is_preprint":false}],"current_model":"NKX2-2 is a homeodomain transcription factor that functions predominantly as a transcriptional repressor by recruiting co-repressor complexes (GRG3/Groucho, HDAC1, DNMT3A) through its Tinman and C-terminal domains to directly bind and silence target gene promoters; it acts downstream of Sonic hedgehog signaling to specify ventral neural tube cell fates (V3 interneurons, oligodendrocytes, serotonergic neurons), downstream of Neurog3 in pancreatic endocrine progenitors to direct beta- and alpha-cell identity by repressing alternative fate genes (notably Arx), and in Ewing's sarcoma as a critical EWS/FLI target that drives oncogenic transformation via transcriptional repression of mesenchymal and differentiation genes, with its NK2-specific domain providing pancreas-specific transcriptional functions distinct from its CNS activities."},"narrative":{"teleology":[{"year":1998,"claim":"Establishing that NKX2-2 is required for terminal beta-cell differentiation resolved the question of which transcription factors drive the final steps of insulin-producing cell maturation in the pancreas.","evidence":"Nkx2.2 null mouse showing failure of beta-cell precursors to express Glut2, Nkx6.1, and mature insulin, with neonatal diabetes","pmids":["9584121"],"confidence":"High","gaps":["Mechanism of NKX2-2 action (activator vs. repressor) unknown","Direct transcriptional targets not identified","Relationship to other endocrine lineage transcription factors undefined"]},{"year":1999,"claim":"Demonstrating that NKX2-2 interprets graded Shh signaling to specify V3 interneuron identity established a dual tissue role for NKX2-2 and revealed it acts as a binary cell-fate switch in ventral neural tube patterning.","evidence":"Nkx2.2 null mouse showing ventral-to-dorsal fate transformation with motor neuron generation instead of V3 interneurons","pmids":["10217145"],"confidence":"High","gaps":["Whether NKX2-2 acts as an activator or repressor of neural fate genes unknown","Redundancy with Nkx2.9 not addressed"]},{"year":2001,"claim":"Showing that NKX2-2 controls oligodendrocyte differentiation timing—both alone and cooperatively with Olig2—expanded its neural role from neuronal to glial fate specification and established its repressor function in the CNS.","evidence":"Nkx2.2 null mouse with delayed oligodendrocyte maturation; Olig2+Nkx2.2 co-expression driving ectopic OPC differentiation in chick spinal cord","pmids":["11567617","11526078"],"confidence":"High","gaps":["Direct target genes mediating oligodendrocyte maturation not identified","Physical interaction between Olig2 and NKX2-2 not yet demonstrated"]},{"year":2002,"claim":"ChIP demonstration that NKX2-2 directly occupies beta-cell gene regulatory regions (insulin, IAPP, Pax4, glucokinase) in vivo established it as a direct transcriptional regulator rather than an indirect developmental signal.","evidence":"Chromatin immunoprecipitation from intact beta cells plus EMSA and reporter assays","pmids":["12426319"],"confidence":"High","gaps":["Whether NKX2-2 activates or represses each target not resolved","Co-factors mediating target selectivity unknown"]},{"year":2003,"claim":"Identifying a physical NKX2-2–Olig2 complex provided the molecular basis for the cross-repressive interaction that establishes the pMN–p3 progenitor domain boundary in the spinal cord.","evidence":"Reciprocal co-immunoprecipitation and yeast two-hybrid with specificity controls (no binding to Nkx6.1 or NeuroD)","pmids":["14573534"],"confidence":"High","gaps":["Domain of interaction not mapped","Functional consequence of disrupting the complex not tested in vivo"]},{"year":2003,"claim":"Placing NKX2-2 in an epistatic cascade with Lmx1b and Pet-1 for serotonergic neuron specification defined a minimal transcription factor code sufficient to drive serotonin cell fate.","evidence":"Lmx1b null mouse plus ectopic co-expression of Nkx2.2+Lmx1b+Pet-1 driving 5-HT differentiation in chick dorsal spinal cord","pmids":["14602809"],"confidence":"High","gaps":["Direct transcriptional targets of NKX2-2 in serotonergic specification unknown","Whether NKX2-2 directly activates Lmx1b or Pet-1 not tested"]},{"year":2005,"claim":"Elucidating NKX2-2's repression mechanism at the MBP promoter—recruitment of an HDAC1–mSin3A complex and competition with activators Puralpha and Sp1—provided the first molecular model for how NKX2-2 controls differentiation timing in oligodendrocyte progenitors.","evidence":"In vitro DNA binding, co-immunoprecipitation of HDAC1–mSin3A complex, Sp1 competition assays, reporter assays","pmids":["15695521"],"confidence":"High","gaps":["In vivo validation of Sp1 competition mechanism not performed","Whether the same co-repressor complex operates in neural tube patterning unknown"]},{"year":2006,"claim":"Identifying NKX2-2 as a critical EWS/FLI target gene necessary for Ewing sarcoma oncogenesis revealed a disease context in which NKX2-2's repressor activity is co-opted for transformation.","evidence":"RNAi knockdown of NKX2-2 abolishing tumorigenic phenotype of Ewing sarcoma cells, with rescue by re-expression","pmids":["16697960"],"confidence":"High","gaps":["Direct transcriptional targets mediating oncogenic transformation not identified","Whether NKX2-2 repressor or activator function drives oncogenesis not resolved"]},{"year":2007,"claim":"Demonstrating that an Engrailed-repressor derivative of NKX2-2 rescues alpha- and partially beta-cell development in null mice, combined with mapping the GRG3 interaction to the Tinman domain, established that NKX2-2's pancreatic function is predominantly repressive.","evidence":"Transgenic dominant-derivative rescue in Nkx2.2 null mice; Co-IP mapping GRG3–Tinman domain interaction","pmids":["17202186"],"confidence":"High","gaps":["Why beta-cell rescue is incomplete not explained","Whether NKX2-2 also has essential activator functions in beta cells not excluded"]},{"year":2008,"claim":"Structure-function dissection in Ewing sarcoma confirmed that the DNA-binding and repressor domains—but not the activation domain—are required for NKX2-2-mediated oncogenesis, and identified TLE/Groucho and HDAC as recruited co-repressors at direct target loci.","evidence":"Domain mutagenesis, ChIP-chip, pharmacological HDAC/TLE blockade, reporter assays in Ewing sarcoma cells","pmids":["18414662"],"confidence":"High","gaps":["Specific target genes driving oncogenesis not individually validated","Whether TLE and HDAC are recruited to the same or distinct target sets unclear"]},{"year":2010,"claim":"Showing that NKX2-2 and NKX2-9 redundantly repress the motor neuron program (including Olig2) in the p3 domain resolved why single NKX2-2 mutants retained partial V3 interneuron specification.","evidence":"Nkx2.2/Nkx2.9 double-mutant mouse with complete loss of V3 interneurons and conversion to motor neuron fate","pmids":["21068056"],"confidence":"High","gaps":["Whether NKX2-9 uses the same co-repressor complexes as NKX2-2 untested","Direct target gene overlap between NKX2-2 and NKX2-9 not mapped"]},{"year":2011,"claim":"Identifying a DNMT3A–GRG3–HDAC1 repression complex recruited by NKX2-2 to the methylated Arx promoter in beta cells provided the molecular mechanism for NKX2-2-mediated beta-versus-alpha cell fate maintenance through epigenetic silencing.","evidence":"Co-IP of NKX2-2 with DNMT3A, GRG3, HDAC1; Tinman domain knock-in mutation in mice; beta-cell-specific DNMT3A deletion; Arx removal rescue; ChIP at Arx promoter","pmids":["22056672"],"confidence":"High","gaps":["Whether NKX2-2 recruits DNMT3A to additional targets beyond Arx unknown","How DNA methylation state feeds back on NKX2-2 binding not addressed"]},{"year":2014,"claim":"Direct ChIP binding of NKX2-2 to the Pdgfra promoter, combined with conditional KO and genetic epistasis, established Pdgfra repression as the key mechanism by which NKX2-2 controls oligodendrocyte differentiation timing.","evidence":"Conditional NKX2-2 KO delaying OPC maturation; NKX2-2 overexpression accelerating it; ChIP showing direct Pdgfra binding; Pdgfra ablation phenocopying NKX2-2 overexpression","pmids":["24449836"],"confidence":"High","gaps":["Whether NKX2-2 represses Pdgfra via the same HDAC1 complex used at MBP/Sirt2 not tested","Post-translational regulation of NKX2-2 during OPC maturation unknown"]},{"year":2014,"claim":"Identification of homozygous NKX2-2 mutations in patients with permanent neonatal diabetes confirmed the conserved requirement for NKX2-2 in human beta-cell development.","evidence":"Homozygosity mapping and Sanger sequencing in consanguineous families with neonatal diabetes","pmids":["24411943"],"confidence":"Medium","gaps":["Functional validation of specific patient mutations not performed","Whether heterozygous carriers have subclinical phenotypes not assessed"]},{"year":2017,"claim":"Neurog3-Cre conditional deletion recapitulating the full null pancreatic phenotype established that NKX2-2 functions specifically within endocrine progenitors downstream of Neurog3, rather than in earlier pancreatic progenitors.","evidence":"Neurog3-Cre-specific Nkx2.2 conditional knockout in mice with immunohistochemistry and gene expression analysis","pmids":["28071588"],"confidence":"High","gaps":["Whether NKX2-2 has any function in pre-Neurog3 progenitors at subthreshold levels not excluded","Direct NKX2-2 targets in the endocrine progenitor transcriptome not comprehensively mapped"]},{"year":2020,"claim":"Domain dissection showing that the Tinman domain recruits GRG3 while the C-terminal domain independently recruits HDAC1 and DNMT3A—with the NK2-specific domain suppressing C-terminal function—revealed a modular co-repressor architecture that explains tissue-specific NKX2-2 activity.","evidence":"Co-IP with domain deletions, in ovo chick spinal cord electroporation assays for oligodendrocyte differentiation","pmids":["31932307"],"confidence":"High","gaps":["Crystal structure of NKX2-2 with co-repressors unavailable","How the NK2-SD suppresses C-terminal domain function mechanistically undefined"]},{"year":2023,"claim":"Endogenous NK2-specific domain mutation selectively impaired beta-cell maturation while sparing CNS functions, establishing that the SD confers pancreas-specific NKX2-2 activity, potentially via chromatin remodeler and nuclear pore complex interactions.","evidence":"Endogenous SD knock-in mutation in mice with parallel beta-cell and CNS phenotyping; proteomics identifying candidate SD interactors","pmids":["37364986"],"confidence":"High","gaps":["SD-interacting chromatin remodelers not individually validated for functional relevance","Whether SD interactions are direct or bridged not resolved"]},{"year":2025,"claim":"Identifying KLF4 as a cofactor that directs NKX2-2 occupancy to alpha-cell-specific promoters revealed how the same transcription factor achieves cell-type-specific target selection within the pancreatic islet.","evidence":"ChIP-seq co-occupancy of NKX2-2 and KLF4; conditional KLF4 KO reducing NKX2-2 binding; KLF4 overexpression in beta cells opening alpha-cell chromatin and recruiting NKX2-2","pmids":["39797760"],"confidence":"High","gaps":["Whether additional cell-type-specific cofactors direct NKX2-2 in beta cells or CNS unknown","Genome-wide NKX2-2 target comparison across all expressing cell types not performed"]},{"year":null,"claim":"The structural basis for NKX2-2's modular co-repressor recruitment, the complete set of cell-type-specific cofactors directing its genomic occupancy, and the mechanism by which the NK2-specific domain suppresses C-terminal repressor function remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model of NKX2-2 in complex with GRG3, HDAC1, or DNMT3A","Complete genome-wide target comparison across NKX2-2-expressing tissues not available","Post-translational regulation of NKX2-2 activity largely unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[14,9,11,23]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,3,7,12,13,14,16]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[19,28]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[7,11,14,16,22]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,3,10,18,22]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,5]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[7,22,31]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,6,25,32]}],"complexes":["NKX2-2–GRG3–HDAC1–DNMT3A repression complex","NKX2-2–HDAC1–mSin3A co-repressor complex","NKX2-2–Olig2 complex"],"partners":["GRG3","HDAC1","DNMT3A","OLIG2","KLF4","CHD4","MSIN3A","PAX4"],"other_free_text":[]},"mechanistic_narrative":"NKX2-2 is a homeodomain transcription factor that functions principally as a transcriptional repressor to specify cell identity in the developing nervous system, pancreas, and intestine. In the ventral neural tube, NKX2-2 acts downstream of Sonic hedgehog to specify V3 interneurons, serotonergic neurons, and oligodendrocytes by repressing alternative fates; it physically interacts with Olig2 to establish progenitor domain boundaries and directly represses target promoters (Pdgfra, MBP, Sirt2) by recruiting an HDAC1–mSin3A co-repressor complex, with its N-terminal Tinman domain recruiting GRG3/Groucho and its C-terminal domain recruiting HDAC1 and DNMT3A [PMID:10217145, PMID:11526078, PMID:14573534, PMID:15695521, PMID:31932307]. In pancreatic endocrine progenitors downstream of Neurog3, NKX2-2 directs beta-cell differentiation by directly occupying and activating beta-cell genes (insulin, MafA, NeuroD1) while repressing alternative-fate genes such as Arx through a DNMT3A–GRG3–HDAC1 repression complex at methylated promoters; its NK2-specific domain confers pancreas-specific functions dispensable for CNS development, and the cofactor KLF4 directs NKX2-2 to alpha-cell-specific promoters [PMID:9584121, PMID:22056672, PMID:28071588, PMID:37364986, PMID:39797760]. Loss-of-function mutations in NKX2-2 cause permanent neonatal diabetes in humans [PMID:24411943]."},"prefetch_data":{"uniprot":{"accession":"O95096","full_name":"Homeobox protein Nkx-2.2","aliases":["Homeobox protein NK-2 homolog B"],"length_aa":273,"mass_kda":30.1,"function":"Transcriptional activator involved in the development of insulin-producting beta cells in the endocrine pancreas (By similarity). May also be involved in specifying diencephalic neuromeric boundaries, and in controlling the expression of genes that play a role in axonal guidance. Binds to elements within the NEUROD1 promoter (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O95096/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NKX2-2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NKX2-2","total_profiled":1310},"omim":[{"mim_id":"617138","title":"SKI FAMILY TRANSCRIPTIONAL COREPRESSOR 2; SKOR2","url":"https://www.omim.org/entry/617138"},{"mim_id":"607808","title":"NK2 HOMEOBOX 4; NKX2-4","url":"https://www.omim.org/entry/607808"},{"mim_id":"606624","title":"NEUROGENIN 2; NEUROG2","url":"https://www.omim.org/entry/606624"},{"mim_id":"606386","title":"OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2; OLIG2","url":"https://www.omim.org/entry/606386"},{"mim_id":"604612","title":"NK2 HOMEOBOX 2; NKX2-2","url":"https://www.omim.org/entry/604612"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":41.9}],"url":"https://www.proteinatlas.org/search/NKX2-2"},"hgnc":{"alias_symbol":["NKX2.2"],"prev_symbol":["NKX2B"]},"alphafold":{"accession":"O95096","domains":[{"cath_id":"1.10.10.60","chopping":"134-189","consensus_level":"medium","plddt":96.7921,"start":134,"end":189}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O95096","model_url":"https://alphafold.ebi.ac.uk/files/AF-O95096-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O95096-F1-predicted_aligned_error_v6.png","plddt_mean":63.09},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NKX2-2","jax_strain_url":"https://www.jax.org/strain/search?query=NKX2-2"},"sequence":{"accession":"O95096","fasta_url":"https://rest.uniprot.org/uniprotkb/O95096.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O95096/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O95096"}},"corpus_meta":[{"pmid":"10217145","id":"PMC_10217145","title":"Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10217145","citation_count":604,"is_preprint":false},{"pmid":"9584121","id":"PMC_9584121","title":"Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9584121","citation_count":512,"is_preprint":false},{"pmid":"11567617","id":"PMC_11567617","title":"The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2.","date":"2001","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/11567617","citation_count":478,"is_preprint":false},{"pmid":"11076772","id":"PMC_11076772","title":"Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11076772","citation_count":426,"is_preprint":false},{"pmid":"11526078","id":"PMC_11526078","title":"Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11526078","citation_count":315,"is_preprint":false},{"pmid":"16697960","id":"PMC_16697960","title":"Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.","date":"2006","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/16697960","citation_count":296,"is_preprint":false},{"pmid":"15519240","id":"PMC_15519240","title":"Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS.","date":"2004","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/15519240","citation_count":244,"is_preprint":false},{"pmid":"11830569","id":"PMC_11830569","title":"Dual origin of spinal oligodendrocyte progenitors and evidence for the cooperative role of Olig2 and Nkx2.2 in the control of oligodendrocyte differentiation.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11830569","citation_count":177,"is_preprint":false},{"pmid":"22056672","id":"PMC_22056672","title":"Nkx2.2 repressor complex regulates islet β-cell specification and prevents β-to-α-cell reprogramming.","date":"2011","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/22056672","citation_count":164,"is_preprint":false},{"pmid":"15698615","id":"PMC_15698615","title":"Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.","date":"2005","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15698615","citation_count":162,"is_preprint":false},{"pmid":"28071588","id":"PMC_28071588","title":"Genetic evidence that Nkx2.2 acts primarily downstream of Neurog3 in pancreatic endocrine lineage development.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28071588","citation_count":154,"is_preprint":false},{"pmid":"22446943","id":"PMC_22446943","title":"NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.","date":"2012","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22446943","citation_count":153,"is_preprint":false},{"pmid":"26847175","id":"PMC_26847175","title":"Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.","date":"2016","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/26847175","citation_count":145,"is_preprint":false},{"pmid":"14602809","id":"PMC_14602809","title":"Lmx1b, Pet-1, and Nkx2.2 coordinately specify serotonergic neurotransmitter phenotype.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14602809","citation_count":140,"is_preprint":false},{"pmid":"24449836","id":"PMC_24449836","title":"Genetic evidence that Nkx2.2 and Pdgfra are major determinants of the timing of oligodendrocyte differentiation in the developing CNS.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24449836","citation_count":123,"is_preprint":false},{"pmid":"9347917","id":"PMC_9347917","title":"Expression patterns of Brx1 (Rieg gene), Sonic hedgehog, Nkx2.2, Dlx1 and Arx during zona limitans intrathalamica and embryonic ventral lateral geniculate nuclear formation.","date":"1997","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9347917","citation_count":121,"is_preprint":false},{"pmid":"18414662","id":"PMC_18414662","title":"EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18414662","citation_count":119,"is_preprint":false},{"pmid":"11262237","id":"PMC_11262237","title":"Distinct sites of origin of oligodendrocytes and somatic motoneurons in the chick spinal cord: oligodendrocytes arise from Nkx2.2-expressing progenitors by a Shh-dependent mechanism.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11262237","citation_count":119,"is_preprint":false},{"pmid":"14729487","id":"PMC_14729487","title":"The concerted activities of Pax4 and Nkx2.2 are essential to initiate pancreatic beta-cell differentiation.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/14729487","citation_count":117,"is_preprint":false},{"pmid":"24411943","id":"PMC_24411943","title":"Analysis of transcription factors key for mouse pancreatic development establishes NKX2-2 and MNX1 mutations as causes of neonatal diabetes in man.","date":"2014","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24411943","citation_count":114,"is_preprint":false},{"pmid":"16847327","id":"PMC_16847327","title":"FoxA2, Nkx2.2, and PDX-1 regulate islet beta-cell-specific mafA expression through conserved sequences located between base pairs -8118 and -7750 upstream from the transcription start site.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16847327","citation_count":102,"is_preprint":false},{"pmid":"17456846","id":"PMC_17456846","title":"Nkx2.2 regulates beta-cell function in the mature islet.","date":"2007","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/17456846","citation_count":85,"is_preprint":false},{"pmid":"25031013","id":"PMC_25031013","title":"The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.","date":"2014","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25031013","citation_count":84,"is_preprint":false},{"pmid":"12426319","id":"PMC_12426319","title":"Transcription factor occupancy of the insulin gene in vivo. Evidence for direct regulation by Nkx2.2.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12426319","citation_count":81,"is_preprint":false},{"pmid":"19780200","id":"PMC_19780200","title":"Co-localization of Nkx6.2 and Nkx2.2 homeodomain proteins in differentiated myelinating oligodendrocytes.","date":"2010","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/19780200","citation_count":80,"is_preprint":false},{"pmid":"18022152","id":"PMC_18022152","title":"Nkx2.2 regulates cell fate choice in the enteroendocrine cell lineages of the intestine.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18022152","citation_count":80,"is_preprint":false},{"pmid":"18538132","id":"PMC_18538132","title":"Nkx2.2 antisense RNA overexpression enhanced oligodendrocytic differentiation.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18538132","citation_count":71,"is_preprint":false},{"pmid":"21059263","id":"PMC_21059263","title":"Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma.","date":"2010","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21059263","citation_count":70,"is_preprint":false},{"pmid":"21669943","id":"PMC_21669943","title":"Sirt2 is a novel in vivo downstream target of Nkx2.2 and enhances oligodendroglial cell differentiation.","date":"2011","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21669943","citation_count":67,"is_preprint":false},{"pmid":"15048854","id":"PMC_15048854","title":"Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination.","date":"2004","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/15048854","citation_count":63,"is_preprint":false},{"pmid":"17202186","id":"PMC_17202186","title":"Nkx2.2-repressor activity is sufficient to specify alpha-cells and a small number of beta-cells in the pancreatic islet.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17202186","citation_count":61,"is_preprint":false},{"pmid":"15695521","id":"PMC_15695521","title":"Stage-specific expression of myelin basic protein in oligodendrocytes involves Nkx2.2-mediated repression that is relieved by the Sp1 transcription factor.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15695521","citation_count":60,"is_preprint":false},{"pmid":"17146289","id":"PMC_17146289","title":"Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.","date":"2006","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17146289","citation_count":59,"is_preprint":false},{"pmid":"14573534","id":"PMC_14573534","title":"Cross-repressive interaction of the Olig2 and Nkx2.2 transcription factors in developing neural tube associated with formation of a specific physical complex.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14573534","citation_count":55,"is_preprint":false},{"pmid":"19759004","id":"PMC_19759004","title":"Cooperative transcriptional regulation of the essential pancreatic islet gene NeuroD1 (beta2) by Nkx2.2 and neurogenin 3.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19759004","citation_count":51,"is_preprint":false},{"pmid":"30376220","id":"PMC_30376220","title":"NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.","date":"2018","source":"Cancer cytopathology","url":"https://pubmed.ncbi.nlm.nih.gov/30376220","citation_count":50,"is_preprint":false},{"pmid":"12915306","id":"PMC_12915306","title":"Co-expression pattern of Shh with Prox1 and that of Nkx2.2 with Mash1 in mouse taste bud.","date":"2003","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/12915306","citation_count":45,"is_preprint":false},{"pmid":"27287799","id":"PMC_27287799","title":"The novel enterochromaffin marker Lmx1a regulates serotonin biosynthesis in enteroendocrine cell lineages downstream of Nkx2.2.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27287799","citation_count":42,"is_preprint":false},{"pmid":"21068056","id":"PMC_21068056","title":"The transcription factors Nkx2.2 and Nkx2.9 play a novel role in floor plate development and commissural axon guidance.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21068056","citation_count":41,"is_preprint":false},{"pmid":"21856296","id":"PMC_21856296","title":"Nkx2.2 and Arx genetically interact to regulate pancreatic endocrine cell development and endocrine hormone expression.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21856296","citation_count":40,"is_preprint":false},{"pmid":"26000096","id":"PMC_26000096","title":"EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma.","date":"2015","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26000096","citation_count":38,"is_preprint":false},{"pmid":"28616785","id":"PMC_28616785","title":"Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.","date":"2017","source":"Head and neck pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28616785","citation_count":38,"is_preprint":false},{"pmid":"16015683","id":"PMC_16015683","title":"Differentiation of embryonic stem cells into insulin-producing cells promoted by Nkx2.2 gene transfer.","date":"2005","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/16015683","citation_count":36,"is_preprint":false},{"pmid":"24979729","id":"PMC_24979729","title":"Mammalian Nkx2.2+ perineurial glia are essential for motor nerve development.","date":"2014","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/24979729","citation_count":35,"is_preprint":false},{"pmid":"18987169","id":"PMC_18987169","title":"Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors.","date":"2008","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18987169","citation_count":32,"is_preprint":false},{"pmid":"31932307","id":"PMC_31932307","title":"The transcription factor NKX2-2 regulates oligodendrocyte differentiation through domain-specific interactions with transcriptional corepressors.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31932307","citation_count":28,"is_preprint":false},{"pmid":"20003319","id":"PMC_20003319","title":"Identification of known and novel pancreas genes expressed downstream of Nkx2.2 during development.","date":"2009","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20003319","citation_count":27,"is_preprint":false},{"pmid":"28864350","id":"PMC_28864350","title":"Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors.","date":"2017","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/28864350","citation_count":26,"is_preprint":false},{"pmid":"21880149","id":"PMC_21880149","title":"Arx and Nkx2.2 compound deficiency redirects pancreatic alpha- and beta-cell differentiation to a somatostatin/ghrelin co-expressing cell lineage.","date":"2011","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21880149","citation_count":25,"is_preprint":false},{"pmid":"24835010","id":"PMC_24835010","title":"C-Abl inhibitor imatinib enhances insulin production by β cells: c-Abl negatively regulates insulin production via interfering with the expression of NKx2.2 and GLUT-2.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24835010","citation_count":24,"is_preprint":false},{"pmid":"21169405","id":"PMC_21169405","title":"NKX2.2 suppresses self-renewal of glioma-initiating cells.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21169405","citation_count":23,"is_preprint":false},{"pmid":"23494546","id":"PMC_23494546","title":"Generation of mice encoding a conditional allele of Nkx2.2.","date":"2013","source":"Transgenic research","url":"https://pubmed.ncbi.nlm.nih.gov/23494546","citation_count":22,"is_preprint":false},{"pmid":"21415915","id":"PMC_21415915","title":"Ontogenetic distribution of the transcription factor nkx2.2 in the developing forebrain of Xenopus laevis.","date":"2011","source":"Frontiers in neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/21415915","citation_count":22,"is_preprint":false},{"pmid":"29713473","id":"PMC_29713473","title":"NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors.","date":"2018","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/29713473","citation_count":20,"is_preprint":false},{"pmid":"23996959","id":"PMC_23996959","title":"Nkx2.2:Cre knock-in mouse line: a novel tool for pancreas- and CNS-specific gene deletion.","date":"2013","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/23996959","citation_count":20,"is_preprint":false},{"pmid":"26492922","id":"PMC_26492922","title":"Nkx2.2 is expressed in a subset of enteroendocrine cells with expanded lineage potential.","date":"2015","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26492922","citation_count":19,"is_preprint":false},{"pmid":"10772886","id":"PMC_10772886","title":"The homeodomain of Nkx2.2 carries two cooperatively acting nuclear localization signals.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10772886","citation_count":17,"is_preprint":false},{"pmid":"14504237","id":"PMC_14504237","title":"Undulated short-tail deletion mutation in the mouse ablates Pax1 and leads to ectopic activation of neighboring Nkx2-2 in domains that normally express Pax1.","date":"2003","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14504237","citation_count":17,"is_preprint":false},{"pmid":"30680064","id":"PMC_30680064","title":"NKL homeobox gene NKX2-2 is aberrantly expressed in Hodgkin lymphoma.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/30680064","citation_count":16,"is_preprint":false},{"pmid":"30210629","id":"PMC_30210629","title":"NKX2-2 Suppresses Osteosarcoma Metastasis and Proliferation by Downregulating Multiple Target Genes.","date":"2018","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30210629","citation_count":15,"is_preprint":false},{"pmid":"22539496","id":"PMC_22539496","title":"Generation of Nkx2.2:lacZ mice using recombination-mediated cassette exchange technology.","date":"2012","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/22539496","citation_count":15,"is_preprint":false},{"pmid":"19965928","id":"PMC_19965928","title":"Nkx2.2 activates the ghrelin promoter in pancreatic islet cells.","date":"2009","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19965928","citation_count":15,"is_preprint":false},{"pmid":"25919494","id":"PMC_25919494","title":"Nkx2.2 and Nkx2.9 are the key regulators to determine cell fate of branchial and visceral motor neurons in caudal hindbrain.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25919494","citation_count":14,"is_preprint":false},{"pmid":"25699080","id":"PMC_25699080","title":"Regulation of the Human Ghrelin Promoter Activity by Transcription Factors, NF-κB and Nkx2.2.","date":"2015","source":"International journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25699080","citation_count":13,"is_preprint":false},{"pmid":"24401371","id":"PMC_24401371","title":"Nato3 plays an integral role in dorsoventral patterning of the spinal cord by segregating floor plate/p3 fates via Nkx2.2 suppression and Foxa2 maintenance.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24401371","citation_count":13,"is_preprint":false},{"pmid":"32818257","id":"PMC_32818257","title":"NKX2-2 Mutation Causes Congenital Diabetes and Infantile Obesity With Paradoxical Glucose-Induced Ghrelin Secretion.","date":"2020","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32818257","citation_count":13,"is_preprint":false},{"pmid":"19258013","id":"PMC_19258013","title":"Spatially distinct functions of PAX6 and NKX2.2 during gliogenesis in the ventral spinal cord.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19258013","citation_count":12,"is_preprint":false},{"pmid":"37364986","id":"PMC_37364986","title":"Major β cell-specific functions of NKX2.2 are mediated via the NK2-specific domain.","date":"2023","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/37364986","citation_count":11,"is_preprint":false},{"pmid":"35815619","id":"PMC_35815619","title":"Gata2, Nkx2-2 and Skor2 form a transcription factor network regulating development of a midbrain GABAergic neuron subtype with characteristics of REM-sleep regulatory neurons.","date":"2022","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35815619","citation_count":11,"is_preprint":false},{"pmid":"24821492","id":"PMC_24821492","title":"Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2.","date":"2014","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24821492","citation_count":11,"is_preprint":false},{"pmid":"17600517","id":"PMC_17600517","title":"Nkx2.2 expression in differentiation of oligodendrocyte precursor cells and inhibitory factors for differentiation of oligodendrocytes after traumatic spinal cord injury.","date":"2007","source":"Journal of neurotrauma","url":"https://pubmed.ncbi.nlm.nih.gov/17600517","citation_count":11,"is_preprint":false},{"pmid":"20951692","id":"PMC_20951692","title":"Genetically-defined lineage tracing of Nkx2.2-expressing cells in chick spinal cord.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20951692","citation_count":10,"is_preprint":false},{"pmid":"34097879","id":"PMC_34097879","title":"Nkx2-2 expressing taste cells in endoderm-derived taste papillae are committed to the type III lineage.","date":"2021","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34097879","citation_count":10,"is_preprint":false},{"pmid":"21352540","id":"PMC_21352540","title":"Novel computational analysis of protein binding array data identifies direct targets of Nkx2.2 in the pancreas.","date":"2011","source":"BMC bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21352540","citation_count":9,"is_preprint":false},{"pmid":"22433950","id":"PMC_22433950","title":"Ectopic transgenic expression of NKX2.2 induces differentiation of adult pancreatic progenitors and mediates islet regeneration.","date":"2012","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/22433950","citation_count":8,"is_preprint":false},{"pmid":"25948942","id":"PMC_25948942","title":"Upregulation of NKX2.2, a target of EWSR1/FLI1 fusion transcript, in primary renal Ewing sarcoma.","date":"2015","source":"Journal of cytology","url":"https://pubmed.ncbi.nlm.nih.gov/25948942","citation_count":7,"is_preprint":false},{"pmid":"29295693","id":"PMC_29295693","title":"Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development.","date":"2020","source":"Current cancer drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/29295693","citation_count":6,"is_preprint":false},{"pmid":"25840610","id":"PMC_25840610","title":"Generation of a Nkx2.2(Cre) knock-in mouse line: Analysis of cell lineages in the central nervous system.","date":"2015","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/25840610","citation_count":6,"is_preprint":false},{"pmid":"38546197","id":"PMC_38546197","title":"The myelination-associated G protein-coupled receptor 37 is regulated by Zfp488, Nkx2.2, and Sox10 during oligodendrocyte differentiation.","date":"2024","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/38546197","citation_count":6,"is_preprint":false},{"pmid":"20599218","id":"PMC_20599218","title":"Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site.","date":"2010","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/20599218","citation_count":6,"is_preprint":false},{"pmid":"32716131","id":"PMC_32716131","title":"Rapid induction of gliogenesis in OLIG2 and NKX2.2-expressing progenitors-derived spheroids.","date":"2020","source":"Stem cells translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32716131","citation_count":5,"is_preprint":false},{"pmid":"27956177","id":"PMC_27956177","title":"Nuclear import of Nkx2-2 is mediated by multiple pathways.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27956177","citation_count":5,"is_preprint":false},{"pmid":"38234938","id":"PMC_38234938","title":"Expression of NKX2.2 in Non-Ewing Tumors With Round Cell Morphology.","date":"2023","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/38234938","citation_count":5,"is_preprint":false},{"pmid":"34584801","id":"PMC_34584801","title":"Ewing Sarcoma and Ewing-Like Sarcoma and the Role of NKX2.2 Immunoreactivity.","date":"2021","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/34584801","citation_count":5,"is_preprint":false},{"pmid":"38689254","id":"PMC_38689254","title":"NKX2-2 based nuclei sorting on frozen human archival pancreas enables the enrichment of islet endocrine populations for single-nucleus RNA sequencing.","date":"2024","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/38689254","citation_count":4,"is_preprint":false},{"pmid":"36656211","id":"PMC_36656211","title":"Correlation NKX2.2 IHC and EWSR1 break-apart FISH in the diagnosis of Ewing sarcoma: Can combined NKX2.2 and CD99 immunoexpression obviate or minimize the need of FISH testing? First assessment study from Indian tertiary cancer care center.","date":"2023","source":"Indian journal of pathology & microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/36656211","citation_count":4,"is_preprint":false},{"pmid":"37399332","id":"PMC_37399332","title":"Differential use of the Nkx2.2 NK2 domain in developing pancreatic islets and neurons.","date":"2023","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/37399332","citation_count":3,"is_preprint":false},{"pmid":"35236160","id":"PMC_35236160","title":"The Roles of Different Multigene Combinations of Pdx1, Ngn3, Sox9, Pax4, and Nkx2.2 in the Reprogramming of Canine ADSCs Into IPCs.","date":"2022","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/35236160","citation_count":3,"is_preprint":false},{"pmid":"39460795","id":"PMC_39460795","title":"Differential regulation of Shh-Gli1 cell signalling pathway on homeodomain transcription factors Nkx2.2 and Pax6 during the medulloblastoma genesis.","date":"2024","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/39460795","citation_count":3,"is_preprint":false},{"pmid":"36999306","id":"PMC_36999306","title":"CD99 and NKX2.2 positive neuroblastoma diagnosed on cytology: A potential diagnostic pitfall and necessity of pathological evaluation of the primary site.","date":"2023","source":"Diagnostic cytopathology","url":"https://pubmed.ncbi.nlm.nih.gov/36999306","citation_count":3,"is_preprint":false},{"pmid":"23284718","id":"PMC_23284718","title":"Nkx2.2+ progenitors generate somatic motoneurons in the chick spinal cord.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23284718","citation_count":3,"is_preprint":false},{"pmid":"38649148","id":"PMC_38649148","title":"Clinicopathologic Correlates of PIT1 and SF1-Multilineage Pituitary Neuroendocrine Tumors and the Diagnostic Utility of NKX2.2 Immunohistochemistry in Pituitary Pathology.","date":"2025","source":"Archives of pathology & laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38649148","citation_count":3,"is_preprint":false},{"pmid":"37191854","id":"PMC_37191854","title":"Role of Gltp in Maturation of Oligodendrocytes Under the Regulation of Nkx2.2.","date":"2023","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/37191854","citation_count":2,"is_preprint":false},{"pmid":"39797760","id":"PMC_39797760","title":"NKX2.2 and KLF4 cooperate to regulate α-cell identity.","date":"2025","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/39797760","citation_count":2,"is_preprint":false},{"pmid":"35152629","id":"PMC_35152629","title":"[Expression and diagnostic value of NKX3.1 and NKX2.2 in mesenchymal chondrosarcoma].","date":"2022","source":"Zhonghua bing li xue za zhi = Chinese journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/35152629","citation_count":1,"is_preprint":false},{"pmid":"40667117","id":"PMC_40667117","title":"CHD4 and NKX2.2 Cooperate to Regulate Beta Cell Function by Repressing Non-Beta Cell Gene Programs.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40667117","citation_count":1,"is_preprint":false},{"pmid":"37821536","id":"PMC_37821536","title":"A novel stop-loss mutation in NKX2-2 gene as a cause of neonatal diabetes mellitus: molecular characterization and structural analysis.","date":"2023","source":"Acta diabetologica","url":"https://pubmed.ncbi.nlm.nih.gov/37821536","citation_count":1,"is_preprint":false},{"pmid":"39415990","id":"PMC_39415990","title":"Independent control of neurogenesis and dorsoventral patterning by NKX2-2.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39415990","citation_count":0,"is_preprint":false},{"pmid":"38223000","id":"PMC_38223000","title":"Homeodomain Transcription Factors Nkx2.2 and Pax6 as Novel Biomarkers for Meningioma Tumor Treatment.","date":"2022","source":"Indian journal of clinical biochemistry : IJCB","url":"https://pubmed.ncbi.nlm.nih.gov/38223000","citation_count":0,"is_preprint":false},{"pmid":"37891121","id":"PMC_37891121","title":"Evaluation of EWSR1/FUS rearrangements by FISH and NKX2.2 immunoexpression in simple bone cysts of the jaw.","date":"2023","source":"Oral surgery, oral medicine, oral pathology and oral radiology","url":"https://pubmed.ncbi.nlm.nih.gov/37891121","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51183,"output_tokens":8544,"usd":0.140854},"stage2":{"model":"claude-opus-4-6","input_tokens":12345,"output_tokens":4605,"usd":0.265275},"total_usd":0.406129,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Nkx2.2 is required for interpreting graded Sonic hedgehog signals and specifying ventral interneuron identity in the neural tube; in Nkx2.2 mutants, progenitor cells undergo a ventral-to-dorsal fate transformation and generate motor neurons rather than V3 interneurons, demonstrating Nkx2.2 has a primary role in neuronal patterning downstream of Shh.\",\n      \"method\": \"Genetic loss-of-function (Nkx2.2 null mouse), immunohistochemistry, in situ hybridization for cell-type markers\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, replicated across multiple labs\",\n      \"pmids\": [\"10217145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Nkx2.2 is required for the final differentiation of pancreatic beta cells; in its absence, beta-cell precursors expressing IAPP and Pdx1 fail to complete differentiation and lack Glut2 and Nkx6.1, resulting in severe neonatal hyperglycemia and death.\",\n      \"method\": \"Genetic loss-of-function (Nkx2.2 null mouse), immunohistochemistry, in situ hybridization\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, foundational paper with >500 citations\",\n      \"pmids\": [\"9584121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Coexpression of Olig2 with Nkx2.2 in the spinal cord promotes ectopic and precocious oligodendrocyte differentiation; both proteins function as transcriptional repressors in this context, and the effect is blocked by Neurogenin1.\",\n      \"method\": \"In vivo misexpression/overexpression in chick spinal cord, reporter assays, loss-of-function analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gain-of-function plus epistasis with Neurogenin1, >400 citations\",\n      \"pmids\": [\"11567617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Nkx2.2 controls the differentiation and maturation of oligodendrocyte progenitors; loss of Nkx2.2 dramatically retards MBP+ and PLP-DM20+ oligodendrocyte differentiation, and overproduction of Nkx2.2 in fibroblasts can induce PLP promoter expression, demonstrating direct regulation of oligodendrocyte differentiation.\",\n      \"method\": \"Nkx2.2 null mouse loss-of-function, in vitro overexpression/reporter assay, immunohistochemistry\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO plus gain-of-function with defined phenotypic readout, >300 citations\",\n      \"pmids\": [\"11526078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation; Nkx6.1/Nkx2.2 double mutant islet development is identical to Nkx2.2 single mutant, placing Nkx6.1 downstream of Nkx2.2 via genetic epistasis.\",\n      \"method\": \"Genetic epistasis — Nkx6.1/Nkx2.2 double-mutant mouse analysis, immunohistochemistry\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double-mutant epistasis experiment, >400 citations\",\n      \"pmids\": [\"11076772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NKX2.2 is a critical target gene of EWS/FLI in Ewing's sarcoma; ongoing EWS/FLI expression induces NKX2.2, and NKX2.2 is necessary for the tumorigenic/oncogenic transformation phenotype of Ewing's sarcoma cells.\",\n      \"method\": \"Retroviral-mediated RNA interference knockdown, reexpression studies, gene expression profiling\",\n      \"journal\": \"Cancer Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — RNAi knockdown plus reexpression rescue with functional oncogenic phenotype readout, >290 citations\",\n      \"pmids\": [\"16697960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NKX2.2 mediates transcriptional repression downstream of EWS/FLI in Ewing's sarcoma; the DNA-binding and repressor domains are required for oncogenesis while the activation domain is dispensable; NKX2.2 recruits TLE (Groucho) and HDAC co-repressors; ChIP-chip confirmed direct binding of NKX2.2 to repressed target gene loci.\",\n      \"method\": \"Structure-function mutagenesis, microarray, ChIP-chip, pharmacological blockade of TLE/HDAC, reporter assays\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — structure-function mutagenesis plus ChIP-chip and pharmacological epistasis, multiple orthogonal methods\",\n      \"pmids\": [\"18414662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nkx2.2 forms a large repression complex in pancreatic beta cells that includes DNMT3a, Grg3, and HDAC1; the Tinman (TN) domain of Nkx2.2 mediates interaction with Grg3; Nkx2.2 preferentially recruits Grg3 and HDAC1 to the methylated Arx promoter in beta cells to repress Arx and prevent beta-to-alpha cell transdifferentiation.\",\n      \"method\": \"Co-immunoprecipitation, endogenous TN-domain knock-in mutation in mice, beta-cell-specific DNMT3a deletion, Arx removal rescue experiment, ChIP\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including Co-IP, in vivo knock-in mutagenesis, conditional KO rescue\",\n      \"pmids\": [\"22056672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Olig2 forms a physical protein complex with Nkx2.2 in mammalian cells and yeast two-hybrid assays; this interaction is specific (Olig2 does not bind Nkx6.1; Nkx2.2 does not bind NeuroD); physical complex formation underlies the cross-repressive interaction that establishes the pMN-p3 boundary in the developing spinal cord.\",\n      \"method\": \"Co-immunoprecipitation, yeast two-hybrid, deletion mapping\",\n      \"journal\": \"Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus yeast two-hybrid with specificity controls\",\n      \"pmids\": [\"14573534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Nkx2.2 is a key regulator of the timing of oligodendrocyte differentiation; induced Nkx2.2 expression causes precocious OPC differentiation while conditional ablation delays maturation; Nkx2.2 directly binds the Pdgfra promoter and represses its expression; genetic ablation of Pdgfra mimics Nkx2.2 overexpression in accelerating OPC differentiation.\",\n      \"method\": \"Conditional knockout, overexpression, ChIP (Nkx2.2 binding to Pdgfra promoter), genetic epistasis (Pdgfra ablation)\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo conditional KO plus ChIP plus genetic epistasis, multiple orthogonal methods\",\n      \"pmids\": [\"24449836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Lmx1b and Pet-1 act downstream of Nkx2.2 to specify the serotonergic neurotransmitter phenotype; ectopic expression of all three (Lmx1b + Pet-1 + Nkx2.2) drives 5-HT differentiation in dorsal spinal cord, defining a molecular pathway necessary and sufficient for serotonergic fate.\",\n      \"method\": \"Genetic loss-of-function (Lmx1b null mice), ectopic gain-of-function in chick spinal cord, epistasis analysis\",\n      \"journal\": \"Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis defined by KO and ectopic expression reconstitution in vivo\",\n      \"pmids\": [\"14602809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Nkx2.2 represses myelin basic protein (MBP) gene expression in oligodendrocyte progenitors by binding two regulatory elements in the MBP promoter, recruiting an HDAC1-mSin3A co-repressor complex, and blocking binding of the activator Puralpha; Sp1 can compete off Nkx2.2 binding and reverse repression, thereby allowing MBP expression in mature oligodendrocytes.\",\n      \"method\": \"In vitro DNA binding assays, promoter reporter assays, co-immunoprecipitation (HDAC1-mSin3A complex), competition assays\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro binding plus Co-IP of co-repressor complex plus in vivo reporter assays\",\n      \"pmids\": [\"15695521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Nkx2.2 repressor activity (via Engrailed-repressor fusion) is sufficient to fully rescue glucagon-producing alpha-cells and partially rescue beta-cells in Nkx2.2 null mice; Grg3 physically interacts with Nkx2.2 through its TN domain in the embryonic pancreas, mediating co-repressor function.\",\n      \"method\": \"Transgenic dominant-derivative rescue in Nkx2.2 null mice, co-immunoprecipitation (Nkx2.2-Grg3 interaction via TN domain), immunohistochemistry\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo rescue plus Co-IP with domain mapping\",\n      \"pmids\": [\"17202186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nkx2.2 cooperatively activates NeuroD1 transcription with Ngn3; Nkx2.2 directly binds one NeuroD1 promoter element and indirectly regulates another; Nkx2.2 is necessary to maintain high NeuroD1 expression in developing islets and mature beta cells, placing Nkx2.2 upstream of NeuroD1.\",\n      \"method\": \"Genetic loss-of-function (Nkx2.2 null mouse and zebrafish morpholino), ChIP, reporter assays, promoter mutagenesis\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo KO plus ChIP plus promoter mutagenesis in two species\",\n      \"pmids\": [\"19759004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Nkx2.2 directly occupies insulin gene control region sequences in intact beta cells in vivo; Nkx2.2 also binds to regulatory regions of islet amyloid polypeptide, Pax4, and glucokinase genes in vivo, demonstrating direct transcriptional regulation of multiple islet beta-cell genes.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) from intact beta cells, in vitro DNA binding (EMSA), transient transfection reporter assays\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vivo ChIP plus in vitro binding confirmation, multiple target genes\",\n      \"pmids\": [\"12426319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Nkx2.2 is required in the mature beta cell for maintenance of MafA and Glut2 expression, insulin gene expression, pancreatic insulin content, and glucose-stimulated insulin secretion; a dominant repressor derivative of Nkx2.2 disrupts endogenous Nkx2.2 function in adult beta cells, causing glucose intolerance and diabetes.\",\n      \"method\": \"Transgenic mouse overexpression of Nkx2.2 repressor derivative in adult beta cells, metabolic phenotyping, gene expression analysis\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — transgenic dominant-negative approach with defined molecular and metabolic phenotypes\",\n      \"pmids\": [\"17456846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FoxA2, Nkx2.2, and PDX-1 directly bind a conserved beta-cell-specific region (region 3, bp -8118 to -7750) of the mafA promoter in vivo and cooperatively activate mafA transcription; Nkx2.2 binding at bp -7771 to -7746 mediates region 3 activation.\",\n      \"method\": \"ChIP, reporter assays, promoter mutagenesis, siRNA knockdown of PDX-1\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo ChIP plus mutagenesis plus functional reporter assays\",\n      \"pmids\": [\"16847327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nkx2.2 directly binds the Sirt2 promoter via HDAC1 in oligodendroglial precursor (CG4) cells, negatively regulating Sirt2 expression; HDAC1 knockdown attenuates Nkx2.2 binding and releases Sirt2 repression; Nkx2.2 overexpression down-regulates Sirt2 and delays CG4 cell differentiation.\",\n      \"method\": \"ChIP (Nkx2.2 and HDAC1 binding to Sirt2 promoter), siRNA knockdown of HDAC1, overexpression of Nkx2.2 and Sirt2 in CG4 cells, reporter assays\",\n      \"journal\": \"Journal of Molecular Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP plus HDAC1 knockdown epistasis plus overexpression phenotype\",\n      \"pmids\": [\"21669943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Nkx2.2 and Nkx2.9 are required together to establish V3 interneuron fate by repressing the motor neuron lineage program (including Olig2) in the p3 domain; double mutant mice lack V3 interneurons and show conversion to motor neuron fate; additionally, both factors are required for floor plate development and commissural axon guidance.\",\n      \"method\": \"Nkx2.2/Nkx2.9 double-mutant mouse, cell fate analysis, axon tracing, locomotor activity assays\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — double-mutant genetic epistasis with multiple cellular phenotypic readouts\",\n      \"pmids\": [\"21068056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The homeodomain of Nkx2.2 contains two cooperatively acting nuclear localization signals (NLS): a proximal NLS (KKRKRR) at the N-terminus of the homeodomain and a distal NLS (RYKMKRAR) at its C-terminus; each NLS is individually sufficient but inefficient for nuclear transport, and both act cooperatively for complete nuclear import.\",\n      \"method\": \"Deletion mutagenesis, nuclear localization assays in transfected cells\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with localization readout, single lab\",\n      \"pmids\": [\"10772886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Pax4 and Nkx2.2 genetically interact to initiate pancreatic beta-cell differentiation; loss of Pax4 prevents expression of Pdx1, HB9, and insulin in beta-cell precursors, and this role is accomplished via genetic interaction with Nkx2.2.\",\n      \"method\": \"Pax4 knockout mouse, immunohistochemistry, genetic interaction analysis\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined phenotype, genetic interaction inferred but not fully epistatic double mutant\",\n      \"pmids\": [\"14729487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Nkx2.2 regulates cell fate choices in intestinal enteroendocrine cell lineages; in Nkx2.2 null mice, several hormone-producing enteroendocrine populations are absent/reduced and ghrelin-producing cells expand; Nkx2.2 functions upstream of Pax6 in intestinal enteroendocrine cell fate.\",\n      \"method\": \"Nkx2.2 null mouse, immunohistochemistry, RT-PCR, Pax6 expression analysis as downstream marker\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cell fate phenotype and epistasis placement upstream of Pax6\",\n      \"pmids\": [\"18022152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Nkx2.2 acts primarily downstream of Neurog3 (endocrine progenitor cells) and functions as an integral component of a modular regulatory program to specify pancreatic islet cell fates; Neurog3-Cre-specific deletion of Nkx2.2 recapitulates the full Nkx2.2 null pancreatic phenotype, demonstrating essential activity in the endocrine progenitor population.\",\n      \"method\": \"Neurog3-Cre conditional knockout of Nkx2.2, immunohistochemistry, gene expression analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific conditional KO with defined phenotypic and molecular readouts\",\n      \"pmids\": [\"28071588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nkx2.2 directly binds to and activates the ghrelin promoter in multiple cell lines; the promoter region between -619 and -488 bp upstream of the translational start site is necessary for repression of ghrelin in alpha and beta cell lines; upregulation of ghrelin in Nkx2.2 null mice is not due to loss of promoter repression but suggests Nkx2.2 contributes to ghrelin activation in epsilon cells.\",\n      \"method\": \"Promoter reporter assays, ChIP, Nkx2.2 null mouse analysis, luciferase deletion constructs\",\n      \"journal\": \"Molecular Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus reporter assays, single lab\",\n      \"pmids\": [\"19965928\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NKX2-2 regulates oligodendrocyte differentiation through domain-specific co-repressor interactions: the N-terminal Tinman (TN) domain recruits GRG3, while the C-terminal domain recruits HDAC1 and DNMT3A; these domains synergistically promote oligodendrocyte differentiation; the NK2-specific domain suppresses the C-terminal domain function in oligodendrocyte differentiation.\",\n      \"method\": \"Co-immunoprecipitation, in ovo electroporation in chick spinal cord, domain deletion mutagenesis, immunofluorescence, in situ hybridization\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — Co-IP with domain mutagenesis plus in vivo functional assay\",\n      \"pmids\": [\"31932307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NKX2.2 mediates EWS/FLI-controlled repression of mesenchymal features in Ewing sarcoma; NKX2.2 represses cell adhesion and extracellular matrix genes including zyxin; NKX2.2-depleted cells display increased focal adhesions, actin stress fibers, cell spreading, migration, and substrate adhesion.\",\n      \"method\": \"RNA sequencing, NKX2.2 knockdown, immunofluorescence of focal adhesion markers, migration assays\",\n      \"journal\": \"Genes & Cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNA-seq plus KD with defined cellular phenotype, single lab\",\n      \"pmids\": [\"26000096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In the intestine, Nkx2.2 regulates enteroendocrine cell specification in a stage-dependent manner; serotonin-producing enterochromaffin cells are most severely reduced in all Nkx2.2 mutant conditions; Lmx1a is expressed in enterochromaffin cells and functions downstream of Nkx2.2; Lmx1a deficiency reduces Tph1 expression.\",\n      \"method\": \"Stage- and cell-type-specific conditional Nkx2.2 deletion, Lmx1a knockout mouse, immunohistochemistry, RT-PCR\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple conditional KOs with epistasis showing Lmx1a downstream of Nkx2.2\",\n      \"pmids\": [\"27287799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The NK2-specific domain (SD) of NKX2.2 is required for beta-cell-specific functions: SD mutation prevents developmental progression of beta-cell precursors into mature insulin-expressing beta cells and impairs adult beta-cell function; SD-dependent effects may be mediated via interactions with chromatin remodelers and nuclear pore complex components; the SD is dispensable for NKX2.2-dependent CNS cell type development.\",\n      \"method\": \"Endogenous SD knock-in mutation in mice, beta-cell phenotyping, gene expression analysis, proteomics/interaction studies\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — endogenous domain knock-in mutation with parallel tissue comparison, multiple phenotypic and molecular readouts\",\n      \"pmids\": [\"37364986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Nuclear import of Nkx2-2 is mediated by multiple pathways: importin alpha1/beta1 (classical pathway), direct importin beta1 binding, and direct importin 13 binding; mutation of NLS1 or NLS2 reduces binding to importin beta1 but not to importin alpha1 or importin 13.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down, in vitro nuclear import assays, siRNA knockdown of importins, NLS mutagenesis\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro import assays plus pull-down plus mutagenesis, single lab\",\n      \"pmids\": [\"27956177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NKX2-2 represses the proneural gene NEUROG2 by two distinct mechanisms in rodent versus human spinal progenitors: in rodents, NKX2-2 represses Olig2 via the Tinman domain leading to loss of Neurog2; in human vpMN progenitors, NKX2-2 represses NEUROG2 but not OLIG2 via a Notch- and Tinman-independent mechanism, allowing protracted motor neurogenesis; ectopic tinman-mutant Nkx2-2 in mouse pMNs phenocopies human vpMNs.\",\n      \"method\": \"In vivo mouse pMN ectopic expression of tinman-mutant Nkx2-2, human and rodent spinal organoid/progenitor analysis, gene expression studies\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — domain mutagenesis with in vivo functional readout in two species, single preprint\",\n      \"pmids\": [\"39415990\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CHD4 (chromodomain helicase DNA-binding protein 4) is an NKX2.2 interacting partner identified by unbiased proteomics; CHD4 and NKX2.2 cooperatively bind and repress non-beta-cell genes in beta cells, including Kcnj5 (GIRK4); aberrant GIRK4 upregulation upon Chd4 deletion impairs glucose-stimulated insulin secretion.\",\n      \"method\": \"Unbiased proteomics screen, co-immunoprecipitation, conditional Chd4 beta-cell KO mouse, gene expression analysis, calcium signaling assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — proteomics-identified interaction confirmed by Co-IP plus conditional KO with defined molecular phenotype, preprint\",\n      \"pmids\": [\"40667117\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"KLF4 is expressed preferentially in pancreatic alpha cells, co-occupies NKX2.2-bound alpha-cell promoters, is necessary for NKX2.2 promoter occupancy in alpha cells, and coregulates NKX2.2 alpha-cell transcriptional targets; KLF4 overexpression in beta cells manipulates chromatin accessibility and increases NKX2.2 binding at alpha-cell-specific promoters.\",\n      \"method\": \"ChIP-seq (NKX2.2 and KLF4 co-occupancy), conditional/cell-type-specific KO, Klf4 overexpression in beta cells, chromatin accessibility (ATAC-seq)\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-seq co-occupancy plus conditional KO plus gain-of-function with chromatin readout\",\n      \"pmids\": [\"39797760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NKX2-2 mutations cause permanent neonatal diabetes in humans, confirming the conserved role of NKX2-2 in human beta-cell development analogous to its role in mice.\",\n      \"method\": \"Homozygosity analysis and Sanger sequencing in consanguineous neonatal diabetes patients; phenotypic comparison to mouse KO\",\n      \"journal\": \"Cell Metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — human genetics with phenotypic correspondence to mouse KO; functional mechanism inferred by analogy\",\n      \"pmids\": [\"24411943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Mammalian Nkx2.2+ perineurial glia are essential for motor nerve development and Schwann cell differentiation; in mice lacking Nkx2.2, motor nerve development is impaired, demonstrating a role for Nkx2.2+ CNS-derived cells in peripheral nervous system formation.\",\n      \"method\": \"Nkx2.2:EGFP transgenic reporter, Nkx2.2 null mouse loss-of-function, immunolabeling, RNA expression analysis\",\n      \"journal\": \"Developmental Dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined cellular phenotype in perineurial glia, single lab\",\n      \"pmids\": [\"24979729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nkx2.2 and Arx genetically interact to regulate pancreatic endocrine cell specification; in Nkx2.2 null background, Arx is necessary for ghrelin mRNA upregulation in epsilon cells but not for ghrelin cell expansion; in absence of Arx, Nkx2.2 becomes essential for repression of somatostatin gene expression.\",\n      \"method\": \"Nkx2.2/Arx compound conditional knockout in pancreatic progenitors, immunohistochemistry, RT-PCR\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — double-mutant genetic analysis with defined hormone expression phenotypes\",\n      \"pmids\": [\"21856296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Gata2, Nkx2-2, and Skor2 form a transcription factor network regulating development of midbrain GABAergic REM-sleep regulatory neurons; Gata2 is required for Nkx2-2 expression, and both Gata2 and Nkx2-2 are required for Skor2 expression in GABAergic precursors, placing Nkx2-2 downstream of Gata2 and upstream of Skor2.\",\n      \"method\": \"Gata2 and Nkx2-2 conditional knockout mice, immunohistochemistry, REM sleep activity assays, axon projection analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in multiple KO backgrounds with neuronal phenotype and functional readout\",\n      \"pmids\": [\"35815619\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NKX2-2 is a homeodomain transcription factor that functions predominantly as a transcriptional repressor by recruiting co-repressor complexes (GRG3/Groucho, HDAC1, DNMT3A) through its Tinman and C-terminal domains to directly bind and silence target gene promoters; it acts downstream of Sonic hedgehog signaling to specify ventral neural tube cell fates (V3 interneurons, oligodendrocytes, serotonergic neurons), downstream of Neurog3 in pancreatic endocrine progenitors to direct beta- and alpha-cell identity by repressing alternative fate genes (notably Arx), and in Ewing's sarcoma as a critical EWS/FLI target that drives oncogenic transformation via transcriptional repression of mesenchymal and differentiation genes, with its NK2-specific domain providing pancreas-specific transcriptional functions distinct from its CNS activities.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NKX2-2 is a homeodomain transcription factor that functions principally as a transcriptional repressor to specify cell identity in the developing nervous system, pancreas, and intestine. In the ventral neural tube, NKX2-2 acts downstream of Sonic hedgehog to specify V3 interneurons, serotonergic neurons, and oligodendrocytes by repressing alternative fates; it physically interacts with Olig2 to establish progenitor domain boundaries and directly represses target promoters (Pdgfra, MBP, Sirt2) by recruiting an HDAC1–mSin3A co-repressor complex, with its N-terminal Tinman domain recruiting GRG3/Groucho and its C-terminal domain recruiting HDAC1 and DNMT3A [PMID:10217145, PMID:11526078, PMID:14573534, PMID:15695521, PMID:31932307]. In pancreatic endocrine progenitors downstream of Neurog3, NKX2-2 directs beta-cell differentiation by directly occupying and activating beta-cell genes (insulin, MafA, NeuroD1) while repressing alternative-fate genes such as Arx through a DNMT3A–GRG3–HDAC1 repression complex at methylated promoters; its NK2-specific domain confers pancreas-specific functions dispensable for CNS development, and the cofactor KLF4 directs NKX2-2 to alpha-cell-specific promoters [PMID:9584121, PMID:22056672, PMID:28071588, PMID:37364986, PMID:39797760]. Loss-of-function mutations in NKX2-2 cause permanent neonatal diabetes in humans [PMID:24411943].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing that NKX2-2 is required for terminal beta-cell differentiation resolved the question of which transcription factors drive the final steps of insulin-producing cell maturation in the pancreas.\",\n      \"evidence\": \"Nkx2.2 null mouse showing failure of beta-cell precursors to express Glut2, Nkx6.1, and mature insulin, with neonatal diabetes\",\n      \"pmids\": [\"9584121\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of NKX2-2 action (activator vs. repressor) unknown\", \"Direct transcriptional targets not identified\", \"Relationship to other endocrine lineage transcription factors undefined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that NKX2-2 interprets graded Shh signaling to specify V3 interneuron identity established a dual tissue role for NKX2-2 and revealed it acts as a binary cell-fate switch in ventral neural tube patterning.\",\n      \"evidence\": \"Nkx2.2 null mouse showing ventral-to-dorsal fate transformation with motor neuron generation instead of V3 interneurons\",\n      \"pmids\": [\"10217145\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NKX2-2 acts as an activator or repressor of neural fate genes unknown\", \"Redundancy with Nkx2.9 not addressed\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showing that NKX2-2 controls oligodendrocyte differentiation timing—both alone and cooperatively with Olig2—expanded its neural role from neuronal to glial fate specification and established its repressor function in the CNS.\",\n      \"evidence\": \"Nkx2.2 null mouse with delayed oligodendrocyte maturation; Olig2+Nkx2.2 co-expression driving ectopic OPC differentiation in chick spinal cord\",\n      \"pmids\": [\"11567617\", \"11526078\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct target genes mediating oligodendrocyte maturation not identified\", \"Physical interaction between Olig2 and NKX2-2 not yet demonstrated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"ChIP demonstration that NKX2-2 directly occupies beta-cell gene regulatory regions (insulin, IAPP, Pax4, glucokinase) in vivo established it as a direct transcriptional regulator rather than an indirect developmental signal.\",\n      \"evidence\": \"Chromatin immunoprecipitation from intact beta cells plus EMSA and reporter assays\",\n      \"pmids\": [\"12426319\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NKX2-2 activates or represses each target not resolved\", \"Co-factors mediating target selectivity unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying a physical NKX2-2–Olig2 complex provided the molecular basis for the cross-repressive interaction that establishes the pMN–p3 progenitor domain boundary in the spinal cord.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation and yeast two-hybrid with specificity controls (no binding to Nkx6.1 or NeuroD)\",\n      \"pmids\": [\"14573534\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Domain of interaction not mapped\", \"Functional consequence of disrupting the complex not tested in vivo\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Placing NKX2-2 in an epistatic cascade with Lmx1b and Pet-1 for serotonergic neuron specification defined a minimal transcription factor code sufficient to drive serotonin cell fate.\",\n      \"evidence\": \"Lmx1b null mouse plus ectopic co-expression of Nkx2.2+Lmx1b+Pet-1 driving 5-HT differentiation in chick dorsal spinal cord\",\n      \"pmids\": [\"14602809\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets of NKX2-2 in serotonergic specification unknown\", \"Whether NKX2-2 directly activates Lmx1b or Pet-1 not tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Elucidating NKX2-2's repression mechanism at the MBP promoter—recruitment of an HDAC1–mSin3A complex and competition with activators Puralpha and Sp1—provided the first molecular model for how NKX2-2 controls differentiation timing in oligodendrocyte progenitors.\",\n      \"evidence\": \"In vitro DNA binding, co-immunoprecipitation of HDAC1–mSin3A complex, Sp1 competition assays, reporter assays\",\n      \"pmids\": [\"15695521\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo validation of Sp1 competition mechanism not performed\", \"Whether the same co-repressor complex operates in neural tube patterning unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying NKX2-2 as a critical EWS/FLI target gene necessary for Ewing sarcoma oncogenesis revealed a disease context in which NKX2-2's repressor activity is co-opted for transformation.\",\n      \"evidence\": \"RNAi knockdown of NKX2-2 abolishing tumorigenic phenotype of Ewing sarcoma cells, with rescue by re-expression\",\n      \"pmids\": [\"16697960\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets mediating oncogenic transformation not identified\", \"Whether NKX2-2 repressor or activator function drives oncogenesis not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating that an Engrailed-repressor derivative of NKX2-2 rescues alpha- and partially beta-cell development in null mice, combined with mapping the GRG3 interaction to the Tinman domain, established that NKX2-2's pancreatic function is predominantly repressive.\",\n      \"evidence\": \"Transgenic dominant-derivative rescue in Nkx2.2 null mice; Co-IP mapping GRG3–Tinman domain interaction\",\n      \"pmids\": [\"17202186\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why beta-cell rescue is incomplete not explained\", \"Whether NKX2-2 also has essential activator functions in beta cells not excluded\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Structure-function dissection in Ewing sarcoma confirmed that the DNA-binding and repressor domains—but not the activation domain—are required for NKX2-2-mediated oncogenesis, and identified TLE/Groucho and HDAC as recruited co-repressors at direct target loci.\",\n      \"evidence\": \"Domain mutagenesis, ChIP-chip, pharmacological HDAC/TLE blockade, reporter assays in Ewing sarcoma cells\",\n      \"pmids\": [\"18414662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific target genes driving oncogenesis not individually validated\", \"Whether TLE and HDAC are recruited to the same or distinct target sets unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showing that NKX2-2 and NKX2-9 redundantly repress the motor neuron program (including Olig2) in the p3 domain resolved why single NKX2-2 mutants retained partial V3 interneuron specification.\",\n      \"evidence\": \"Nkx2.2/Nkx2.9 double-mutant mouse with complete loss of V3 interneurons and conversion to motor neuron fate\",\n      \"pmids\": [\"21068056\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NKX2-9 uses the same co-repressor complexes as NKX2-2 untested\", \"Direct target gene overlap between NKX2-2 and NKX2-9 not mapped\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identifying a DNMT3A–GRG3–HDAC1 repression complex recruited by NKX2-2 to the methylated Arx promoter in beta cells provided the molecular mechanism for NKX2-2-mediated beta-versus-alpha cell fate maintenance through epigenetic silencing.\",\n      \"evidence\": \"Co-IP of NKX2-2 with DNMT3A, GRG3, HDAC1; Tinman domain knock-in mutation in mice; beta-cell-specific DNMT3A deletion; Arx removal rescue; ChIP at Arx promoter\",\n      \"pmids\": [\"22056672\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NKX2-2 recruits DNMT3A to additional targets beyond Arx unknown\", \"How DNA methylation state feeds back on NKX2-2 binding not addressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Direct ChIP binding of NKX2-2 to the Pdgfra promoter, combined with conditional KO and genetic epistasis, established Pdgfra repression as the key mechanism by which NKX2-2 controls oligodendrocyte differentiation timing.\",\n      \"evidence\": \"Conditional NKX2-2 KO delaying OPC maturation; NKX2-2 overexpression accelerating it; ChIP showing direct Pdgfra binding; Pdgfra ablation phenocopying NKX2-2 overexpression\",\n      \"pmids\": [\"24449836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NKX2-2 represses Pdgfra via the same HDAC1 complex used at MBP/Sirt2 not tested\", \"Post-translational regulation of NKX2-2 during OPC maturation unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of homozygous NKX2-2 mutations in patients with permanent neonatal diabetes confirmed the conserved requirement for NKX2-2 in human beta-cell development.\",\n      \"evidence\": \"Homozygosity mapping and Sanger sequencing in consanguineous families with neonatal diabetes\",\n      \"pmids\": [\"24411943\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional validation of specific patient mutations not performed\", \"Whether heterozygous carriers have subclinical phenotypes not assessed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Neurog3-Cre conditional deletion recapitulating the full null pancreatic phenotype established that NKX2-2 functions specifically within endocrine progenitors downstream of Neurog3, rather than in earlier pancreatic progenitors.\",\n      \"evidence\": \"Neurog3-Cre-specific Nkx2.2 conditional knockout in mice with immunohistochemistry and gene expression analysis\",\n      \"pmids\": [\"28071588\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NKX2-2 has any function in pre-Neurog3 progenitors at subthreshold levels not excluded\", \"Direct NKX2-2 targets in the endocrine progenitor transcriptome not comprehensively mapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Domain dissection showing that the Tinman domain recruits GRG3 while the C-terminal domain independently recruits HDAC1 and DNMT3A—with the NK2-specific domain suppressing C-terminal function—revealed a modular co-repressor architecture that explains tissue-specific NKX2-2 activity.\",\n      \"evidence\": \"Co-IP with domain deletions, in ovo chick spinal cord electroporation assays for oligodendrocyte differentiation\",\n      \"pmids\": [\"31932307\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of NKX2-2 with co-repressors unavailable\", \"How the NK2-SD suppresses C-terminal domain function mechanistically undefined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Endogenous NK2-specific domain mutation selectively impaired beta-cell maturation while sparing CNS functions, establishing that the SD confers pancreas-specific NKX2-2 activity, potentially via chromatin remodeler and nuclear pore complex interactions.\",\n      \"evidence\": \"Endogenous SD knock-in mutation in mice with parallel beta-cell and CNS phenotyping; proteomics identifying candidate SD interactors\",\n      \"pmids\": [\"37364986\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SD-interacting chromatin remodelers not individually validated for functional relevance\", \"Whether SD interactions are direct or bridged not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identifying KLF4 as a cofactor that directs NKX2-2 occupancy to alpha-cell-specific promoters revealed how the same transcription factor achieves cell-type-specific target selection within the pancreatic islet.\",\n      \"evidence\": \"ChIP-seq co-occupancy of NKX2-2 and KLF4; conditional KLF4 KO reducing NKX2-2 binding; KLF4 overexpression in beta cells opening alpha-cell chromatin and recruiting NKX2-2\",\n      \"pmids\": [\"39797760\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether additional cell-type-specific cofactors direct NKX2-2 in beta cells or CNS unknown\", \"Genome-wide NKX2-2 target comparison across all expressing cell types not performed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for NKX2-2's modular co-repressor recruitment, the complete set of cell-type-specific cofactors directing its genomic occupancy, and the mechanism by which the NK2-specific domain suppresses C-terminal repressor function remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of NKX2-2 in complex with GRG3, HDAC1, or DNMT3A\", \"Complete genome-wide target comparison across NKX2-2-expressing tissues not available\", \"Post-translational regulation of NKX2-2 activity largely unexplored\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [14, 9, 11, 23]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 3, 7, 12, 13, 14, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [19, 28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [7, 11, 14, 16, 22]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 3, 10, 18, 22]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [7, 22, 31]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 6, 25, 32]}\n    ],\n    \"complexes\": [\n      \"NKX2-2–GRG3–HDAC1–DNMT3A repression complex\",\n      \"NKX2-2–HDAC1–mSin3A co-repressor complex\",\n      \"NKX2-2–Olig2 complex\"\n    ],\n    \"partners\": [\n      \"GRG3\",\n      \"HDAC1\",\n      \"DNMT3A\",\n      \"OLIG2\",\n      \"KLF4\",\n      \"CHD4\",\n      \"MSIN3A\",\n      \"PAX4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}